<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39335653</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>20</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>COVID-19 Inflammatory Syndrome: Lessons from TNFRI and CRP about the Risk of Death in Severe Disease.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2138</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines12092138</ELocationID><Abstract><AbstractText><b>Background/Objectives</b>: Cytokine storm in severe COVID-19 is responsible for irreversible tissue damage and death. Soluble mediators from the TNF superfamily, their correlation with clinical outcome, and the use of TNF receptors as a potent predictor for clinical outcome were evaluated. <b>Methods</b>: Severe COVID-19 patients had the levels of soluble mediators from the TNF superfamily quantified and categorized according to the clinical outcome (death versus survival). Statistical modeling was performed to predict clinical outcomes. <b>Results</b>: COVID-19 patients have elevated serum levels from the TNF superfamily. Regardless of sex and age, the sTNFRI levels were observed to be significantly higher in deceased patients from the first weeks following the onset of symptoms. We analyzed hematological parameters and inflammatory markers, and there was a difference between the groups for the following factors: erythrocytes, hemoglobin, hematocrit, leukocytes, neutrophils, band cells, lymphocytes, monocytes, CRP, IL-8, IFN-γ, IL-10, IL-6, IL-4, IL-2, leptin MIF sCD40L, and sTNFRI (<i>p</i> &lt; 0.05). A post hoc analysis showed an inferential capacity over 70% for some hematological markers, CRP, and inflammatory mediators in deceased patients. sTNFRI was strongly associated with death, and the sTNFRI/sTNFRII ratio differed between outcomes (<i>p</i> &lt; 0.001; power above 90%), highlighting the impact of these proteins on clinical results. The final logistic model, including sTNFRI/sTNFRII and CRP, indicated high sensitivity, specificity, accuracy, and an eight-fold higher odds ratio for an unfavorable outcome. <b>Conclusions</b>: The joint use of the sTNFRI/sTNFRII ratio with CRP proves to be a promising tool to assist in the clinical management of patients hospitalized for COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Farnesi-de-Assunção</LastName><ForeName>Thaís Soares</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Parasitology, Federal University of Triângulo Mineiro, Uberaba 38025-180, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira-Scussel</LastName><ForeName>Ana Carolina de Morais</ForeName><Initials>ACM</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Parasitology, Federal University of Triângulo Mineiro, Uberaba 38025-180, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodrigues</LastName><ForeName>Wellington Francisco</ForeName><Initials>WF</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Parasitology, Federal University of Triângulo Mineiro, Uberaba 38025-180, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matos</LastName><ForeName>Beatriz Sodré</ForeName><Initials>BS</Initials><Identifier Source="ORCID">0000-0002-0342-1017</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Parasitology, Federal University of Triângulo Mineiro, Uberaba 38025-180, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silva</LastName><ForeName>Djalma Alexandre Alves</ForeName><Initials>DAA</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Parasitology, Federal University of Triângulo Mineiro, Uberaba 38025-180, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Andrade E Silva</LastName><ForeName>Leonardo Eurípedes</ForeName><Initials>LE</Initials><Identifier Source="ORCID">0000-0002-0485-229X</Identifier><AffiliationInfo><Affiliation>Clinical Analysis and Pathological Anatomy Laboratory, Empresa Brasileira de Serviços Hospitalares (EBSERH), Federal University of Triângulo Mineiro, Uberaba 38025-180, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mundim</LastName><ForeName>Fabiano Vilela</ForeName><Initials>FV</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Parasitology, Federal University of Triângulo Mineiro, Uberaba 38025-180, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helmo</LastName><ForeName>Fernanda Rodrigues</ForeName><Initials>FR</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Parasitology, Federal University of Triângulo Mineiro, Uberaba 38025-180, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernardes E Borges</LastName><ForeName>Anna Victória</ForeName><Initials>AV</Initials><Identifier Source="ORCID">0000-0003-0453-0394</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Parasitology, Federal University of Triângulo Mineiro, Uberaba 38025-180, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desidério</LastName><ForeName>Chamberttan Souza</ForeName><Initials>CS</Initials><Identifier Source="ORCID">0000-0003-4399-0633</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Parasitology, Federal University of Triângulo Mineiro, Uberaba 38025-180, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trevisan</LastName><ForeName>Rafael Obata</ForeName><Initials>RO</Initials><Identifier Source="ORCID">0000-0002-4509-9142</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Parasitology, Federal University of Triângulo Mineiro, Uberaba 38025-180, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Obata</LastName><ForeName>Malu Mateus Santos</ForeName><Initials>MMS</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Parasitology, Federal University of Triângulo Mineiro, Uberaba 38025-180, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbosa</LastName><ForeName>Laís Milagres</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Parasitology, Federal University of Triângulo Mineiro, Uberaba 38025-180, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lemes</LastName><ForeName>Marcela Rezende</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Parasitology, Federal University of Triângulo Mineiro, Uberaba 38025-180, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa-Madeira</LastName><ForeName>Juliana Cristina</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Parasitology, Federal University of Triângulo Mineiro, Uberaba 38025-180, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbosa</LastName><ForeName>Rafaela Miranda</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Parasitology, Federal University of Triângulo Mineiro, Uberaba 38025-180, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cunha</LastName><ForeName>Andrezza Cristina Cancian Hortolani</ForeName><Initials>ACCH</Initials><AffiliationInfo><Affiliation>Hematological Research Laboratory, Federal University of Triângulo Mineiro, Uberaba 38025-180, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>Loren Queli</ForeName><Initials>LQ</Initials><AffiliationInfo><Affiliation>Hematological Research Laboratory, Federal University of Triângulo Mineiro, Uberaba 38025-180, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Sarah Cristina Sato Vaz</ForeName><Initials>SCSV</Initials><AffiliationInfo><Affiliation>Hematological Research Laboratory, Federal University of Triângulo Mineiro, Uberaba 38025-180, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Vito</LastName><ForeName>Fernanda Bernadelli</ForeName><Initials>FB</Initials><Identifier Source="ORCID">0000-0002-7407-4972</Identifier><AffiliationInfo><Affiliation>Hematological Research Laboratory, Federal University of Triângulo Mineiro, Uberaba 38025-180, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monteiro</LastName><ForeName>Ivan Borges</ForeName><Initials>IB</Initials><AffiliationInfo><Affiliation>UNIMED São Domingos Hospital, Uberaba 38025-110, MG, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Alencar Gomes da Silva Regional Hospital, Uberaba 38060-200, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferreira</LastName><ForeName>Yulsef Moura</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Alencar Gomes da Silva Regional Hospital, Uberaba 38060-200, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Machado</LastName><ForeName>Guilherme Henrique</ForeName><Initials>GH</Initials><AffiliationInfo><Affiliation>Mário Palmério University Hospital, Uberaba 38050-501, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moraes-Souza</LastName><ForeName>Hélio</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Hematological Research Laboratory, Federal University of Triângulo Mineiro, Uberaba 38025-180, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodrigues</LastName><ForeName>Denise Bertulucci Rocha</ForeName><Initials>DBR</Initials><AffiliationInfo><Affiliation>Centro de Formação Especial em Saúde (CEFORES), Federal University of Triângulo Mineiro, Uberaba 38025-180, MG, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology, Medical School, University of Uberaba, Uberaba 38010-200, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Oliveira</LastName><ForeName>Carlo José Freire</ForeName><Initials>CJF</Initials><Identifier Source="ORCID">0000-0003-2211-7333</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Parasitology, Federal University of Triângulo Mineiro, Uberaba 38025-180, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silva</LastName><ForeName>Marcos Vinicius</ForeName><Initials>MV</Initials><Identifier Source="ORCID">0000-0002-2966-7621</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Parasitology, Federal University of Triângulo Mineiro, Uberaba 38025-180, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Júnior</LastName><ForeName>Virmondes Rodrigues</ForeName><Initials>VR</Initials><Identifier Source="ORCID">0000-0001-8706-4223</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Parasitology, Federal University of Triângulo Mineiro, Uberaba 38025-180, MG, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>#668/2020</GrantID><Agency>Fundação Coordenação de Aperfeiçoamento de Pessoal de Nível Superior</Agency><Country /></Grant><Grant><GrantID>313-16</GrantID><Agency>Fundação de Amparo à Pesquisa do Estado de Minas Gerais</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">C-reactive protein</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">TNF receptors</Keyword><Keyword MajorTopicYN="N">TNF superfamily</Keyword><Keyword MajorTopicYN="N">clinical outcomes predictor</Keyword><Keyword MajorTopicYN="N">inflammatory mediators</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39335653</ArticleId><ArticleId IdType="pmc">PMC11428742</ArticleId><ArticleId IdType="doi">10.3390/biomedicines12092138</ArticleId><ArticleId IdType="pii">biomedicines12092138</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Clementi N., Ghosh S., De Santis M., Castelli M., Criscuolo E., Zanoni I., Clementi M., Mancini N. Viral Respiratory Pathogens and Lung Injury. Clin. Microbiol. Rev. 2021;34:10–1128. doi: 10.1128/CMR.00103-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00103-20</ArticleId><ArticleId IdType="pmc">PMC8142519</ArticleId><ArticleId IdType="pubmed">33789928</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbari H., Tabrizi R., Lankarani K.B., Aria H., Vakili S., Asadian F., Noroozi S., Keshavarz P., Faramarz S. The Role of Cytokine Profile and Lymphocyte Subsets in the Severity of Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis. Life Sci. 2020;258:118167. doi: 10.1016/j.lfs.2020.118167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.118167</ArticleId><ArticleId IdType="pmc">PMC7387997</ArticleId><ArticleId IdType="pubmed">32735885</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang L., Yin Z., Hu Y., Mei H. Controlling Cytokine Storm Is Vital in COVID-19. Front. Immunol. 2020;11:3158. doi: 10.3389/fimmu.2020.570993.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.570993</ArticleId><ArticleId IdType="pmc">PMC7734084</ArticleId><ArticleId IdType="pubmed">33329533</ArticleId></ArticleIdList></Reference><Reference><Citation>Leisman D.E., Ronner L., Pinotti R., Taylor M.D., Sinha P., Calfee C.S., Hirayama A.V., Mastroiani F., Turtle C.J., Harhay M.O., et al. Cytokine Elevation in Severe and Critical COVID-19: A Rapid Systematic Review, Meta-Analysis, and Comparison with Other Inflammatory Syndromes. Lancet Respir. Med. 2020;8:1233–1244. doi: 10.1016/S2213-2600(20)30404-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30404-5</ArticleId><ArticleId IdType="pmc">PMC7567529</ArticleId><ArticleId IdType="pubmed">33075298</ArticleId></ArticleIdList></Reference><Reference><Citation>Herbein G., O’Brien W.A. Tumor Necrosis Factor (TNF)-Alpha and TNF Receptors in Viral Pathogenesis. Proc. Soc. Exp. Biol. Med. 2000;223:241–257. doi: 10.1046/j.1525-1373.2000.22335.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1525-1373.2000.22335.x</ArticleId><ArticleId IdType="pubmed">10719836</ArticleId></ArticleIdList></Reference><Reference><Citation>Karki R., Sharma B.R., Tuladhar S., Williams E.P., Zalduondo L., Samir P., Zheng M., Sundaram B., Banoth B., Malireddi R.K.S., et al. Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes. Cell. 2021;184:149–168.e17. doi: 10.1016/j.cell.2020.11.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.11.025</ArticleId><ArticleId IdType="pmc">PMC7674074</ArticleId><ArticleId IdType="pubmed">33278357</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisenhut M., Shin J. Il Pathways in the Pathophysiology of Coronavirus 19 Lung Disease Accessible to Prevention and Treatment. Front. Physiol. 2020;11:872. doi: 10.3389/fphys.2020.00872.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.00872</ArticleId><ArticleId IdType="pmc">PMC7457053</ArticleId><ArticleId IdType="pubmed">32922301</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanamee É.S., Faustman D.L. Structural Principles of Tumor Necrosis Factor Superfamily Signaling. Sci. Signal. 2018;11:eaao4910. doi: 10.1126/scisignal.aao4910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.aao4910</ArticleId><ArticleId IdType="pubmed">29295955</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabal-Hierro L., Lazo P.S. Signal Transduction by Tumor Necrosis Factor Receptors. Cell Signal. 2012;24:1297–1305. doi: 10.1016/j.cellsig.2012.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2012.02.006</ArticleId><ArticleId IdType="pubmed">22374304</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Valle D.M., Kim-Schulze S., Huang H.-H., Beckmann N.D., Nirenberg S., Wang B., Lavin Y., Swartz T.H., Madduri D., Stock A., et al. An Inflammatory Cytokine Signature Predicts COVID-19 Severity and Survival. Nat. Med. 2020;26:1636–1643. doi: 10.1038/s41591-020-1051-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1051-9</ArticleId><ArticleId IdType="pmc">PMC7869028</ArticleId><ArticleId IdType="pubmed">32839624</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellis P.D. The Essential Guide to Effect Sizes. Cambridge University Press; Cambridge, UK: 2010.</Citation></Reference><Reference><Citation>Fritz C.O., Morris P.E., Richler J.J. Effect Size Estimates: Current Use, Calculations, and Interpretation. J. Exp. Psychol. Gen. 2012;141:2–18. doi: 10.1037/a0024338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/a0024338</ArticleId><ArticleId IdType="pubmed">21823805</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues W.F., Miguel C.B., Marques L.C., da Costa T.A., de Abreu M.C.M., Oliveira C.J.F., Lazo-Chica J.E. Predicting Blood Parasite Load and Influence of Expression of INOS on the Effect Size of Clinical Laboratory Parameters in Acute Trypanosoma Cruzi Infection with Different Inoculum Concentrations in C57BL/6 Mice. Front. Immunol. 2022;13:850037. doi: 10.3389/fimmu.2022.850037.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.850037</ArticleId><ArticleId IdType="pmc">PMC8974915</ArticleId><ArticleId IdType="pubmed">35371021</ArticleId></ArticleIdList></Reference><Reference><Citation>Arango H.G. Bioestatística: Teórica E Computacional. Guanabara Koogan SA; Rio de Janeiro, Brazil: 2001.</Citation></Reference><Reference><Citation>Casella G., Berger R. Statistical Inference. Chapman and Hall/CRC; Boca Raton, FL, USA: 2024.</Citation></Reference><Reference><Citation>Ferretti V.V., Klersy C., Bruno R., Cutti S., Nappi R.E. More on Age and Gender in COVID-19. Maturitas. 2022;163:89. doi: 10.1016/j.maturitas.2022.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.maturitas.2022.05.011</ArticleId><ArticleId IdType="pmc">PMC9212765</ArticleId><ArticleId IdType="pubmed">35717261</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramírez-Soto M.C., Ortega-Cáceres G., Arroyo-Hernández H. Sex Differences in COVID-19 Fatality Rate and Risk of Death: An Analysis in 73 Countries, 2020–2021. Infez. Med. 2021;29:402. doi: 10.53854/LIIM-2903-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.53854/LIIM-2903-11</ArticleId><ArticleId IdType="pmc">PMC8805484</ArticleId><ArticleId IdType="pubmed">35146345</ArticleId></ArticleIdList></Reference><Reference><Citation>Teodoro A.G.F., Rodrigues W.F., Farnesi-de-Assunção T.S., Borges A.V.B.E., Obata M.M.S., Neto J.R.D.C., da Silva D.A.A., Andrade-Silva L.E., Desidério C.S., Costa-Madeira J.C., et al. Inflammatory Response and Activation of Coagulation after COVID-19 Infection. Viruses. 2023;15:938. doi: 10.3390/v15040938.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15040938</ArticleId><ArticleId IdType="pmc">PMC10145373</ArticleId><ArticleId IdType="pubmed">37112918</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva D.A.A., de Andrade-Silva L.E., Desidério C.S., Assunção T.S.F.d., Oliveira A.C.d.M., Trevisan R.O., Santos M.M., Helmo F.R., Barbosa L.M., Costa-Madeira J.C., et al. Relation between Hematological and Biochemical Parameters per Days of Symptoms in Hospitalized Patients with Flu-like Syndrome and COVID-19. Res. Soc. Dev. 2022;11:e54411427439. doi: 10.33448/rsd-v11i4.27439.</Citation><ArticleIdList><ArticleId IdType="doi">10.33448/rsd-v11i4.27439</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang S.Q., Huang Q.F., Xie W.M., Lv C., Quan X.Q. The Association between Severe COVID-19 and Low Platelet Count: Evidence from 31 Observational Studies Involving 7613 Participants. Br. J. Haematol. 2020;190:e29–e33. doi: 10.1111/bjh.16817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.16817</ArticleId><ArticleId IdType="pubmed">32420607</ArticleId></ArticleIdList></Reference><Reference><Citation>Gohda Id T., Murakoshi M., Suzuki Y., Hiki M., Naito T., Takahashi K., Tabe Y., Chen R.J. Circulating Tumor Necrosis Factor Receptors Are Associated with Mortality and Disease Severity in COVID-19 Patients. PLoS ONE. 2022;17:e0275745. doi: 10.1371/journal.pone.0275745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0275745</ArticleId><ArticleId IdType="pmc">PMC9553057</ArticleId><ArticleId IdType="pubmed">36219652</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortaz E., Tabarsi P., Jamaati H., Dalil Roofchayee N., Dezfuli N.K., Hashemian S.M.R., Moniri A., Marjani M., Malekmohammad M., Mansouri D., et al. Increased Serum Levels of Soluble TNF-α Receptor Is Associated with ICU Mortality in COVID-19 Patients. Front. Immunol. 2021;12:592727. doi: 10.3389/fimmu.2021.592727.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.592727</ArticleId><ArticleId IdType="pmc">PMC8100036</ArticleId><ArticleId IdType="pubmed">33968010</ArticleId></ArticleIdList></Reference><Reference><Citation>Palacios Y., Ruiz A., Ramón-Luing L.A., Ocaña-Guzman R., Barreto-Rodriguez O., Sánchez-Monciváis A., Tecuatzi-Cadena B., Regalado-García A.G., Pineda-Gudiño R.D., García-Martínez A., et al. Severe COVID-19 Patients Show an Increase in Soluble TNFR1 and ADAM17, with a Relationship to Mortality. Int. J. Mol. Sci. 2021;22:8423. doi: 10.3390/ijms22168423.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22168423</ArticleId><ArticleId IdType="pmc">PMC8395100</ArticleId><ArticleId IdType="pubmed">34445140</ArticleId></ArticleIdList></Reference><Reference><Citation>Fricke-Galindo I., Buendía-Roldán I., Ruiz A., Palacios Y., Pérez-Rubio G., de Jesus Hernández-Zenteno R., Reyes-Melendres F., Zazueta-Márquez A., Alarcón-Dionet A., Guzmán-Vargas J., et al. TNFRSF1B and TNF Variants Are Associated with Differences in Levels of Soluble Tumor Necrosis Factor Receptors in Patients With Severe COVID-19. J. Infect. Dis. 2022;226:778. doi: 10.1093/infdis/jiac101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac101</ArticleId><ArticleId IdType="pmc">PMC8992340</ArticleId><ArticleId IdType="pubmed">35294530</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcos-Ramiro B., García-Weber D., Millán J. TNF-Induced Endothelial Barrier Disruption: Beyond Actin and Rho. Thromb. Haemost. 2014;112:1088–1102. doi: 10.1160/th14-04-0299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/th14-04-0299</ArticleId><ArticleId IdType="pubmed">25078148</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Hauwermeiren F., Vandenbroucke R.E., Libert C. Treatment of TNF Mediated Diseases by Selective Inhibition of Soluble TNF or TNFR1. Cytokine Growth Factor Rev. 2011;22:311–319. doi: 10.1016/j.cytogfr.2011.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2011.09.004</ArticleId><ArticleId IdType="pubmed">21962830</ArticleId></ArticleIdList></Reference><Reference><Citation>Waters J.P., Pober J.S., Bradley J.R. Tumour Necrosis Factor in Infectious Disease. J. Pathol. 2013;230:132–147. doi: 10.1002/path.4187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.4187</ArticleId><ArticleId IdType="pubmed">23460469</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z., Hua S. Transcription Factor-Mediated Signaling Pathways’ Contribution to the Pathology of Acute Lung Injury and Acute Respiratory Distress Syndrome. Am. J. Transl. Res. 2020;12:5608–5618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7540143</ArticleId><ArticleId IdType="pubmed">33042442</ArticleId></ArticleIdList></Reference><Reference><Citation>Popescu I., Snyder M.E., Iasella C.J., Hannan S.J., Koshy R., Burke R., Das A., Brown M.J., Lyons E.J., Lieber S.C., et al. CD41 T-Cell Dysfunction in Severe COVID-19 Disease Is Tumor Necrosis Factor-a/Tumor Necrosis Factor Receptor 1–Dependent. Am. J. Respir. Crit. Care Med. 2022;205:1403–1418. doi: 10.1164/rccm.202111-2493OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202111-2493OC</ArticleId><ArticleId IdType="pmc">PMC9875894</ArticleId><ArticleId IdType="pubmed">35348444</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma D., Malik A., Guy C., Vogel P., Kanneganti T.D. TNF/TNFR Axis Promotes Pyrin Inflammasome Activation and Distinctly Modulates Pyrin Inflammasomopathy. J. Clin. Investig. 2019;129:150–162. doi: 10.1172/JCI121372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI121372</ArticleId><ArticleId IdType="pmc">PMC6307946</ArticleId><ArticleId IdType="pubmed">30457980</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Z., Wu Y. A Systematic Test of Receptor Binding Kinetics for Ligands in Tumor Necrosis Factor Superfamily by Computational Simulations. Int. J. Mol. Sci. 2020;21:1778. doi: 10.3390/ijms21051778.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21051778</ArticleId><ArticleId IdType="pmc">PMC7084274</ArticleId><ArticleId IdType="pubmed">32150842</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultheiß C., Willscher E., Paschold L., Gottschick C., Klee B., Henkes S.S., Bosurgi L., Dutzmann J., Sedding D., Frese T., et al. The IL-1β, IL-6, and TNF Cytokine Triad Is Associated with Post-Acute Sequelae of COVID-19. Cell Rep. Med. 2022;3:100663. doi: 10.1016/j.xcrm.2022.100663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Pober J.S. Activation and Injury of Endothelial Cells by Cytokines. Pathol. Biol. 1998;46:159–163.</Citation><ArticleIdList><ArticleId IdType="pubmed">9769910</ArticleId></ArticleIdList></Reference><Reference><Citation>Okuyama M., Yamaguchi S., Yamaoka M., Nitobe J., Fujii S., Yoshimura T., Tomoike H. Nitric Oxide Enhances Expression and Shedding of Tumor Necrosis Factor Receptor I (P55) in Endothelial Cells. Arterioscler. Thromb. Vasc. Biol. 2000;20:1506–1511. doi: 10.1161/01.ATV.20.6.1506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.ATV.20.6.1506</ArticleId><ArticleId IdType="pubmed">10845865</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleymenov D.A., Bykonia E.N., Popova L.I., Mazunina E.P., Gushchin V.A., Kolobukhina L.V., Burgasova O.A., Kruzhkova I.S., Kuznetsova N.A., Shidlovskaya E.V., et al. A Deep Look Into COVID-19 Severity Through Dynamic Changes in Blood Cytokine Levels. Front. Immunol. 2021;12:771609. doi: 10.3389/fimmu.2021.771609.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.771609</ArticleId><ArticleId IdType="pmc">PMC8630739</ArticleId><ArticleId IdType="pubmed">34858428</ArticleId></ArticleIdList></Reference><Reference><Citation>Onuk S., Sipahioğlu H., Karahan S., Yeşiltepe A., Kuzugüden S., Karabulut A., Beştepe Dursun Z., Akın A. Cytokine Levels and Severity of Illness Scoring Systems to Predict Mortality in COVID-19 Infection. Healthcare. 2023;11:387. doi: 10.3390/healthcare11030387.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare11030387</ArticleId><ArticleId IdType="pmc">PMC9914724</ArticleId><ArticleId IdType="pubmed">36766961</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>